Imagine having a disease that many doctors have never seen before. That's what Marty Verel experienced when he was told he had AL amyloidosis—and it's what hematologist Brendan Weiss, M.D., is determined to help change. For Amyloidosis Awareness Month, Dr. Weiss shares what he's learned studying the rare disease.
Brad Heidrich’s diagnosis with a deadly cancer at age 13 changed the course of his life—and inspired the person he would become: a Janssen scientist dedicated to working on therapies for blood cancer. For Blood Cancer Awareness Month, we share his incredible story.
Johnson & Johnson aspires to change the trajectory of health for humanity. And Tom Heyman helps make that lofty goal a reality through his work as the head of Johnson & Johnson's venture capital division, which invests in dozens of companies each year. He shares what's on his radar for 2019.
From breakthrough work to eradicate some of the world's deadliest diseases to advancements in cutting-edge health technology, see just some of the ways Johnson & Johnson is working to help change the trajectory of health for humanity.
Johnson & Johnson and Chinese company Legend Biotech have teamed up to work on a new form of treatment for the incurable blood cancer. We interview Dr. Sen Zhuang about the unique collaboration—and the promise it holds.
From partnering with the Black AIDS Institute to reduce HIV infection rates to improving representation in clinical trials, learn how Johnson & Johnson has made it a mission to help address disparities in healthcare.
Imagine if your doctor could detect cancer before it began growing in your body, then give you medicine to prevent it from taking hold. This researcher explains how she and other scientists are working to someday make this cutting-edge concept a reality.